Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 20, 2025 10:31 ET | Source: Spark Biomedical

Spark Biomedical Awarded an NIH Grant to Study the Treatment Effects of tAN® for Alcohol Withdrawal Symptoms

DALLAS, TX, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Spark Biomedical, a global leader in wearable, non-invasive neurostimulation devices, has been awarded a $305,000 Phase I STTR grant from the National...
October 15, 2025 09:00 ET | Source: Spark Biomedical

Spark Biomedical Publishes Peer-Reviewed Trial Showing Wearable Device Reduces Heavy Menstrual Bleeding

Dallas, TX, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Spark Biomedical, the parent company of OhmBody, a women’s wellness division focused on wearable neurostimulation technology, has published the first...
August 19, 2025 09:00 ET | Source: Spark Biomedical

Spark Biomedical Awarded Funding from Wellcome Leap for Women’s Health Innovation

Dallas, TX, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Spark Biomedical, the parent company of OhmBody, a women’s wellness division focused on wearable neurostimulation technology, has been selected as one...
July 07, 2025 09:30 ET | Source: Spark Biomedical

OhmBody Launches with a Groundbreaking Wearable Neurostimulation Device Set to Revolutionize Menstrual Wellness

Dallas, TX, July 07, 2025 (GLOBE NEWSWIRE) -- OhmBody, the science-forward women's wellness division of Spark Biomedical reimagining menstrual care, has launched the first wearable device to combine...
June 12, 2025 10:07 ET | Source: Spark Biomedical

Spark Biomedical Completes Enrollment in a Neurostimulation Pivotal Trial for Opioid Use Disorder

Dallas, TX, June 12, 2025 (GLOBE NEWSWIRE) -- Spark Biomedical, a leader in wearable neurostimulation technology, has completed enrollment for its pivotal clinical trial, which aims to improve...
April 30, 2025 10:14 ET | Source: Spark Biomedical

Spark Biomedical Secures $15M Series A To Advance Drug-Free Wearable Neurostimulation Therapies

Dallas, TX, April 30, 2025 (GLOBE NEWSWIRE) -- Spark Biomedical, a leading health tech innovator in wearable neurostimulation technology, has closed its $15M Series A round—led by WAVE Ventures and...
March 24, 2025 10:16 ET | Source: Spark Biomedical

Spark Biomedical Completes Enrollment for Pivotal Trial in Neonatal Opioid Withdrawal Treatment

Dallas, TX, March 24, 2025 (GLOBE NEWSWIRE) -- Spark Biomedical, a leader in wearable neurostimulation technology, has completed enrollment for its pivotal phase II clinical trial, offering hope to...
March 05, 2025 09:48 ET | Source: Spark Biomedical

Spark Biomedical Receives Health Canada’s Medical Device License for Sparrow Ascent Opioid Withdrawal Treatment

Dallas, TX, March 05, 2025 (GLOBE NEWSWIRE) -- Spark Biomedical, a leader in wearable neurostimulation technology, announces the receipt of its Medical Device License from Health Canada for Sparrow...
February 20, 2025 09:37 ET | Source: Spark Biomedical

Spark Biomedical Partners With Air Force To Launch Trial Testing Innovative Solution to Motion Sickness and Spatial Disorientation

Dallas, TX, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Spark Biomedical, a global leader in wearable neurostimulation technology, announces an innovative study to explore the effectiveness of transcutaneous...
November 18, 2024 10:48 ET | Source: Spark Biomedical

Spark Biomedical Sets Sights on Global Expansion with New ISO 13485 and MDSAP Certifications

Dallas, TX, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Spark Biomedical, a leading developer of wearable neurostimulation devices, proudly announces the recent achievement of ISO 13485:2016 and MDSAP Quality...